Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
4.220
+0.090 (2.18%)
At close: Nov 17, 2026, 4:00 PM EST
4.080
-0.140 (-3.32%)
After-hours: Nov 17, 2026, 5:08 PM EST

Passage Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-34.38-43.15-65.17-103-129.29-177.73
Net Income
-33.08-45.52-64.77-102.06-136.13-185.39
Earnings Per Share
-10.33-14.35-21.04-37.29-50.02-69.51
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
20.1646.376.76114.29189.61315.77
Total Debt
-24.0125.4826.2927.11-
Net Cash (Debt)
20.1622.2951.2888162.5315.77
Net Cash Growth
-29.10%-56.53%-41.73%-45.85%-48.54%3.59%
Net Cash Per Share
6.297.0316.6632.1559.71118.39

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-32.65-31.51-47.96-78.26-118.21-126.88
Capital Expenditures
---0.03-0.15-2.27-17.64
Free Cash Flow
-32.65-31.51-47.99-78.41-120.48-144.52
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.